Trials / Enrolling By Invitation
Enrolling By InvitationNCT06045962
Optimal Stent Duration After Ureteroscopy
Effect of Three vs Seven Day Ureteral Stent Removal After Ureteroscopy on Stent Related Symptoms
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 172 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine how soon ureteral stents can be safely removed following surgery.
Detailed description
The rationale for this study is to determine if there is a difference in symptoms or complications among patients undergoing uncomplicated ureteroscopy for stone removal with shorter indwelling stent duration. Currently there are only a few small studies exploring the optimal duration of stent placement after stent placement and no multicenter randomized control trials. The investigation aim is to determine if earlier ureteral stent removal will reduce urinary symptoms after stent removal and improve quality of life without increasing risk of negative side effects. Using questionnaires for stent related symptoms the researchers will assess stent indwelling time effect on patient reported side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ureteral stent | Used to open the ureter and help the kidney drain |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2023-09-21
- Last updated
- 2025-10-03
Locations
11 sites across 2 countries: United States, Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06045962. Inclusion in this directory is not an endorsement.